EP4081303A4 - Composition containing cyclic dipeptide, purine nucleoside and/or amino acid, and chicken extract, production method thereof, and use of cyclic dipeptide, purine nucleoside and/or amino acid, and chicken extract - Google Patents

Composition containing cyclic dipeptide, purine nucleoside and/or amino acid, and chicken extract, production method thereof, and use of cyclic dipeptide, purine nucleoside and/or amino acid, and chicken extract Download PDF

Info

Publication number
EP4081303A4
EP4081303A4 EP20906765.1A EP20906765A EP4081303A4 EP 4081303 A4 EP4081303 A4 EP 4081303A4 EP 20906765 A EP20906765 A EP 20906765A EP 4081303 A4 EP4081303 A4 EP 4081303A4
Authority
EP
European Patent Office
Prior art keywords
amino acid
purine nucleoside
cyclic dipeptide
chicken extract
production method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP20906765.1A
Other languages
German (de)
French (fr)
Other versions
EP4081303A1 (en
Inventor
Yoshihiro Nakao
Shan-May YONG
Chia-Juan LIM
Eric Kian-Shiun SHIM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Holdings Ltd
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of EP4081303A1 publication Critical patent/EP4081303A1/en
Publication of EP4081303A4 publication Critical patent/EP4081303A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/275—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of animal origin, e.g. chitin
    • A23L29/281—Proteins, e.g. gelatin or collagen
    • A23L29/284—Gelatin; Collagen
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP20906765.1A 2019-12-27 2020-06-26 Composition containing cyclic dipeptide, purine nucleoside and/or amino acid, and chicken extract, production method thereof, and use of cyclic dipeptide, purine nucleoside and/or amino acid, and chicken extract Pending EP4081303A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SG10201913617Y 2019-12-27
PCT/JP2020/025296 WO2021131106A1 (en) 2019-12-27 2020-06-26 Composition containing cyclic dipeptide, purine nucleoside and/or amino acid, and chicken extract, production method thereof, and use of cyclic dipeptide, purine nucleoside and/or amino acid, and chicken extract

Publications (2)

Publication Number Publication Date
EP4081303A1 EP4081303A1 (en) 2022-11-02
EP4081303A4 true EP4081303A4 (en) 2024-01-24

Family

ID=76573241

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20906765.1A Pending EP4081303A4 (en) 2019-12-27 2020-06-26 Composition containing cyclic dipeptide, purine nucleoside and/or amino acid, and chicken extract, production method thereof, and use of cyclic dipeptide, purine nucleoside and/or amino acid, and chicken extract

Country Status (6)

Country Link
EP (1) EP4081303A4 (en)
JP (1) JP7545478B2 (en)
CN (1) CN115066273A (en)
AU (1) AU2020412909A1 (en)
TW (1) TW202123958A (en)
WO (1) WO2021131106A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003048850A (en) * 2001-06-01 2003-02-21 Nippon Meat Packers Inc Therapeutic agent of arthropathy, and functional food
RU2255758C2 (en) * 2003-09-18 2005-07-10 Закрытое акционерное общество "Научно-производственное объединение "ТЕХКОН" Biologically active carnosine-anserine-containing complex and method for its preparing
US20070293427A1 (en) * 2006-04-21 2007-12-20 Eric Vouland Hydrolysate of avian cartilage, process of preparation and uses thereof
US20170165314A1 (en) * 2014-03-28 2017-06-15 The University Of Tokyo Agent containing imidazole dipeptide
US20190060415A1 (en) * 2017-08-31 2019-02-28 Lonza Inc. Health promoting composition and methods of use supplement

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009102248A (en) * 2007-10-22 2009-05-14 Lytone Enterpprise Inc Pharmaceutical composition for rapidly decreasing uric acid in blood and package, and use of anserine for rapidly decreasing uric acid in blood
CN101999622A (en) * 2009-09-01 2011-04-06 上海太太乐食品有限公司 Liquid compound seasoning and preparation method thereof
RU2694718C1 (en) * 2018-07-16 2019-07-16 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт пушного звероводства и кролиководства имени В.А. Афанасьева" (ФГБНУ НИИПЗК) Complete feedstuff and method of its use in feeding slaughtering young minks

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003048850A (en) * 2001-06-01 2003-02-21 Nippon Meat Packers Inc Therapeutic agent of arthropathy, and functional food
RU2255758C2 (en) * 2003-09-18 2005-07-10 Закрытое акционерное общество "Научно-производственное объединение "ТЕХКОН" Biologically active carnosine-anserine-containing complex and method for its preparing
US20070293427A1 (en) * 2006-04-21 2007-12-20 Eric Vouland Hydrolysate of avian cartilage, process of preparation and uses thereof
US20170165314A1 (en) * 2014-03-28 2017-06-15 The University Of Tokyo Agent containing imidazole dipeptide
US20190060415A1 (en) * 2017-08-31 2019-02-28 Lonza Inc. Health promoting composition and methods of use supplement

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of WO2021131106A1 *
YUKI TAGA ET AL: "Identification of Collagen-Derived Hydroxyproline (Hyp)-Containing Cyclic Dipeptides with High Oral Bioavailability: Efficient Formation of Cyclo(X-Hyp) from X-Hyp-Gly-Type Tripeptides by Heating", JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, vol. 65, no. 43, 7 October 2017 (2017-10-07), US, pages 9514 - 9521, XP055640765, ISSN: 0021-8561, DOI: 10.1021/acs.jafc.7b03714 *

Also Published As

Publication number Publication date
TW202123958A (en) 2021-07-01
WO2021131106A1 (en) 2021-07-01
CN115066273A (en) 2022-09-16
EP4081303A1 (en) 2022-11-02
JP7545478B2 (en) 2024-09-04
AU2020412909A1 (en) 2022-07-14
JP2023508934A (en) 2023-03-06

Similar Documents

Publication Publication Date Title
EP3429354A4 (en) B-vitamin and amino acid conjugates of nicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof
EP4028026A4 (en) Novel nucleobase editors and methods of using same
EP3761978A4 (en) Inhibitors of protein arginine methyltransferase 5 (prmt5), pharmaceutical products thereof, and methods thereof
EP3845247A4 (en) Application of amino acid nutrient, and pharmaceutical composition including amino acid nutrient
EP3921418A4 (en) Compositions and methods for nucleic acid sequencing
EP3733683A4 (en) Nucleoside analogue, preparation method and application
ZA201906063B (en) Novel 5'-inosinic acid dehydrogenase and method of preparing 5'-inosinic acid using the same
IL289941A (en) Method of making nicotinamide ribofuranoside salts, nicotinamide ribofuranoside salts as such, and uses thereof
EP3773900A4 (en) Hinokitiol analogues, methods of preparing and pharmaceutical compositions thereof
EP3766521A4 (en) Pharmaceutical composition containing 211at-labeled amino acid derivative, and method for producing said pharmaceutical composition
EP3763819A4 (en) Novel promoter and l-amino acid production method using same
EP4069861A4 (en) Methods for cultivating cells, preparation of hydrolysate from cells and applications thereof
EP3984361A4 (en) Plant activator containing amino acid or salt thereof, and oligosaccharide, and use thereof
EP3670661A4 (en) Microorganism producing mycosporine-like amino acid and micosporine-like amino acid production method using same
EP4149916A4 (en) Methods of synthesizing cannabigergol, cannabigerolic acid, and analogs thereof
PH12020550483A1 (en) Anti-apoc3 antibodies and methods of use thereof
EP4081048A4 (en) Oral composition, flavor improving method, flavor improving agent for chicken extract, and use of hydrolyzed collagen type ii
EP3749765A4 (en) Methods and compositions for tracking nucleic acid fragment origin for nucleic acid sequencing
EP4053152A4 (en) Keratin bd-13, preparation method, pharmaceutical composition and use thereof
EP3717489A4 (en) Salts of 4-amino-n-(1-((3-chloro-2-fluorophenyl)amino)-6-methylisoquinolin-5-yl)thieno[3,2-d]pyrimidine-7-carboxamide, and crystalline forms thereof
MX2017010666A (en) (2r,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-met hyloxazole-2-carbonyl)amino]pentanoic acid.
EP3968975A4 (en) Compositions comprising ephedrine or an ephedrine salt and methods of making and using same
EP4081303A4 (en) Composition containing cyclic dipeptide, purine nucleoside and/or amino acid, and chicken extract, production method thereof, and use of cyclic dipeptide, purine nucleoside and/or amino acid, and chicken extract
EP3553171A4 (en) Acetohydroxy acid synthase mutant and method for producing microorganism comprising same or l-branched chain amino acid using same
EP3967328A4 (en) New artificial nucleic acid, production method therefor, and use thereof

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20220715

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20240103

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/708 20060101ALI20231220BHEP

Ipc: A61K 31/405 20060101ALI20231220BHEP

Ipc: A61K 38/12 20060101ALI20231220BHEP

Ipc: A23L 33/18 20160101ALI20231220BHEP

Ipc: A23L 33/175 20160101ALI20231220BHEP

Ipc: A23L 33/10 20160101ALI20231220BHEP

Ipc: A61P 29/00 20060101AFI20231220BHEP